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Abstract: 
Objective  
To evaluate the cost effectiveness of a behavioural therapy intervention 
shown to be clinically effective in comparison with usual care for stroke 
patients with aphasia.  
Design  
Randomised controlled trial with comparison of costs and calculation of 
incremental cost effectiveness ratio.  
Setting  
Community  
Participants  
Participants identified as having low mood on either the Visual Analog 
Mood Scale sad item (>50) or Stroke Aphasic Depression Questionnaire 
Hospital version 21 (SADQH21) (>6) were recruited.  
Interventions  
Participants were randomly allocated to behavioural therapy or usual care 
using internet-based randomisation generated in advance of the study by a 
clinical trials unit.  
Main measures  
Outcomes were assessed at six months after randomisation, blind to group 
allocation. The costs were assessed from a service use questionnaire. 
Effectiveness was defined as the change in SADQH21 scores and a cost-
effectiveness analysis was performed comparing the behavioural group 
with the usual care control group. The cost analysis was undertaken from 
the perspective of the UK NHS and Social Services.  
Results  
At 6 months the SADQH21 score for the intervention group was 20.4 
compared to the control group value of 17.3. This resulted in a mean 
increase of 0.7 in the control group, compared to a mean significant 
different decrease of 6 in the intervention group (p = 0.003). The 
Incremental Cost-Effectiveness Ratio indicated that the cost per point 
reduction on the SADQH21 was £263.  
Conclusion  
The behavioural therapy was found to improve mood and resulted in some 
encouraging savings in resource utilisation over the six months follow up.  
http://mc.manuscriptcentral.com/clinrehab
Clinical Rehabilitation
For Peer Review
  
 
 
Page 1 of 33
http://mc.manuscriptcentral.com/clinrehab
Clinical Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Cost analysis of the Communication and Low Mood (CALM) randomised 
trial of behavioural therapy for stroke patients with aphasia 
 
Ioan Humphreys1 Shirley Thomas2, Ceri Phillips1, Nadina Lincoln2 
 
 
1 Swansea Centre for Health Economics, Swansea University. 
2 Division of Rehabilitation & Ageing, University of Nottingham. 
 
 
Corresponding author: Shirley Thomas, Division of Rehabilitation & Ageing, 
University of Nottingham, School of Medicine, B Floor The Medical School, 
Queens Medical Centre, Nottingham, NG7 2UH, UK. Telephone: +44 (0)115 
8467484, Fax: +44 (0)115 823 0231.  
Email: shirley.thomas@nottingham.ac.uk 
 
 
 
 
 
 
Page 2 of 33
http://mc.manuscriptcentral.com/clinrehab
Clinical Rehabilitation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Abstract  
Objective 
To evaluate the cost effectiveness of a behavioural therapy intervention shown 
to be clinically effective in comparison with usual care for stroke patients with 
aphasia. 
Design  
Randomised controlled trial with comparison of costs and calculation of 
incremental cost effectiveness ratio. 
Setting  
Community 
Participants 
Participants identified as having low mood on either the Visual Analog Mood 
Scale sad item (>50) or Stroke Aphasic Depr ssion Questionnaire Hospital 
version 21 (SADQH21) (>6) were recruited.  
Interventions 
Participants were randomly allocated to behavioural therapy or usual care using 
internet-based randomisation generated in advance of the study by a clinical 
trials unit. 
Main measures 
Outcomes were assessed at six months after randomisation, blind to group 
allocation. The costs were assessed from a service use questionnaire. 
Effectiveness was defined as the change in SADQH21 scores and a cost-
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effectiveness analysis was performed comparing the behavioural group with the 
usual care control group. The cost analysis was undertaken from the perspective 
of the UK NHS and Social Services.  
Results 
The greatest difference was in home help costs where there was a saving of 
£56.20 in the intervention group compared to an increase of £61.40 in the 
control group.  At 6 months the SADQH21 score for the intervention group was 
20.4 compared to the control group value of 17.3. This resulted in a mean 
increase of 0.7 in the control group, compared to a mean significant different 
decrease of 6 in the intervention group (p = 0.003). The Incremental Cost-
Effectiveness Ratio indicated that the cost per point reduction on the SADQH21 
was £263. 
Conclusion 
Overall the behavioural therapy was found to improve mood and resulted in 
some encouraging savings in resource utilisation over the six months follow up.  
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Introduction 
Mood disorders, including depression, anxiety and general psychological distress 
[1] are common following stroke. Depression is the most commonly investigated 
emotional consequence of stroke [1], with an average prevalence of 29%, which 
remains consistent up to 10 years post-stroke [2]. Effective treatment of 
depression following stroke is important as depression is associated with longer 
hospital stay [3], increased healthcare utilisation [4], worse rehabilitation 
outcomes [5,6], increased carer strain [7], lower quality of life [2, 8] and 
increased mortality [2, 9], and so has implications for health care costs and 
resources. Co-morbid long term physical health conditions and mental health 
problems have been found to increase health care costs [10]. 
Behavioural therapy is a practical approach which can be adapted for people with 
aphasia and aims to improve mood by increasing activity levels, particularly the 
frequency of pleasant events.  In a recent randomised controlled trial [13] of 
behavioural therapy compared with usual care for treating low mood in stroke 
patients with aphasia, behavioural therapy was found to improve self-reported 
mood, self-esteem and observer-rated mood at three months after 
randomisation, and observer-rated mood at six months after randomisation 
[13].   A cost analysis was necessary to inform future research and service 
provision. The aim of this study was to assess the costs of behavioural therapy 
for stroke patients with aphasia and the subsequent impact on resource 
utilisation compared to those receiving usual care. 
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Methods 
Cost analysis was conducted as part of a multicentre randomised controlled trial 
evaluating behavioural therapy compared to usual care for treating low mood in 
stroke patients with aphasia (ISRCTN56078830). Ethical approval was granted  
by Nottingham Research Ethics Committee 1. Full details of trial participants and 
procedures are given in a previous publication [13]. 
 
In summary, stroke patients with aphasia were identified from hospital stroke 
wards, community stroke services, speech and language therapists, and stroke 
communication groups in the community. Patients who were blind, deaf, had 
dementia or were unable to speak English prior to the stroke, or were receiving 
treatment for depression at the time of their stroke were excluded.  Participants 
who consented had their mood assessed using the ‘sad’ item of the Visual 
Analog Mood Scales [14] (VAMS) and a relative or carer completed the Stroke 
Aphasic Depression Questionnaire 10-item hospital version [15 (SADQH10).  
Participants identified as having low mood on either measure (VAMS sad >50 or 
SADQH10 >6 [16]) were invited to take part in the trial. There are two versions 
of the SADQH – 10 items and 21 items. We used the 10 item version as a 
baseline screen and the 21 item version for the follow ups. We then prorated the 
baseline scores to create a 21 item score to enable us to compare scores on the 
same metric at all the time points. 
Participants were randomly allocated to behavioural therapy or usual care (1:1 
ratio, stratified by recruitment centre and whether participant was recruited in 
hospital or in the community) using internet-based randomisation generated in 
advance of the study by a clinical trials unit. 
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Participants allocated to receive behavioural therapy were offered up to 20 
treatment sessions over three months, with sessions lasting approximately one 
hour. Therapy was delivered at the participant’s place of residence by an 
assistant psychologist who received weekly supervision from a consultant clinical 
psychologist. Therapy was tailored to the individual’s needs and treatment 
strategies included activity monitoring, activity scheduling and graded task 
assignments. All trial patients received all other services that were available to 
them as local practice. 
The cost analysis was undertaken from the perspective of the UK NHS and Social 
Services. All costs are expressed in British Pound Sterling (GBP). The cost of the 
behaviour therapy intervention was based on the salary of one Band 5 assistant 
psychologist to deliver the intervention (Point 19 £23,589 p.a.) and one Band 8b 
clinical psychologist to provide supervision to the assistant psychologist (Point 
39 £48,983 p.a.) (salaries as at 01/12/12).  Therefore the cost of the 
intervention amounted to £211 per hour. The unit costs of the resources were 
based on PSSRU 2011 [22] as shown in Table 1. 
 
Table 1 about here 
Three and six months after randomisation participants were visited by an 
independent assessor who was blind to group allocation to complete the 
outcome assessments. The primary outcome was the Stroke Aphasic Depression 
Questionnaire 21-item hospital version (SADQH-21); [15]) at six months after 
randomisation. The SADQH-21 was completed by a relative or carer. A decrease 
in score indicates an improvement in mood. Secondary outcomes included the 
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‘sad’ item from the Visual Analog Mood Scales [14], Visual Analogue Self-Esteem 
Scale [17], Nottingham Leisure Questionnaire [18], Carer Strain Index [19] and 
Satisfaction with Care ratings [20]. 
 
Resource use by patient was collected by questionnaire, by an assessor who was 
unaware of group allocation at three months and six months after 
randomisation. The assessor asked how often the following resources had been 
used in the previous three months: visits to or from; General Practitioner, 
Speech and Language Therapist, Occupational Therapist, Physiotherapist, Mental 
Health Nurse and practice nurse. The use of home help services was also 
recorded. As participants in the trial had communication problems the response 
options in the questionnaire were recorded as ‘Never’, ‘Sometimes’ and ‘Often’. 
In order to quantify the number of times that a person utilised  resources  when 
they responded ‘sometimes’ and ‘often’, the frequency was estimated from the 
mean number of visits over a 3-month period reported in previous research 
[21]. This estimate was substituted for the response ‘sometimes’ and the mean 
number plus one standard deviation for the response category ‘often’.  
 
Tests for normality of the data were undertaken, as well as Levene’s test for 
Equality of Variances and T-Tests for Equality of Means. Lack of data normality 
was seen in the three month costs for Speech and Language Therapy, 
Physiotherapy, Practice Nurse, and overall total costs at 6 months. Additional 
non-parametric Mann-Whitney U tests were conducted on these data.  
Chi square tests were conducted to compare the frequency with which resources 
were used by participants in the usual care and behavioural therapy groups at 
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three and six months follow up (see Table 2). All comparisons were not-
significant (p>0.05). 
 
The main analysis evaluated the total costs of the intervention and resource use 
6 months after randomisation, but costs at 3 months follow up were also 
recorded. Additionally, because of the relatively short follow-up period, further 
analysis was undertaken where any % increases or decreases seen between the 
groups were incrementally extrapolated over 24 months and tests for differences 
undertaken. 
 
A cost-effectiveness analysis was performed comparing the behavioural therapy 
group with the usual care control group. Effectiveness was defined as the change 
in SADQH21 scores and a cost-effectiveness analysis was performed using this 
outcome measure. The incremental cost-effectiveness ratio, i.e. the difference in 
average costs divided by the difference in average effects between groups, was 
also calculated. In order to capture the uncertainty around the estimates, 1000 
nonparametric bootstrap replications were generated from the sets of multiply 
imputed data, and mean cost and effect were plotted in a cost effectiveness 
plane. As there are no published data on the threshold willingness to pay value 
for additional effectiveness associated with the group programme described, the 
probability that the programme be considered cost effective was calculated for a 
range of threshold values and presented in a cost effectiveness acceptability 
curve.  
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Results 
Participants 
There were 105 participants originally recruited to the CALM trial, with 51 (49%) 
randomly allocated to behavioural therapy and 54 (51%) to the usual care 
control group. 57 (63%) of the participants were men and the mean age was 67 
years (SD 13.5). The groups were comparable at baseline on disability and 
communication difficulties. The extent of resources used and their associated 
costs were calculated for both the three month and six month follow up 
assessment points. Finally, baseline levels of disability, mood or aphasia as 
groups were comparable at baseline on these characteristics.  
Because of the way that that the values from Shaw [21] were used to estimate  
the number of times a resource was used in each three month period,  the data 
was skewed and not normally distributed. Therefore, the categories of resources 
used (Never, Sometimes and Often) were cross tabulated with group allocation 
and chi-squared analysis conducted.   
Out of the 105 patients randomly allocated, there were missing data and 
withdrawals in both groups. Outcome assessments (including resource utilisation 
data) were completed with 88 participants at 3 months (48 usual care, 40 
behavioural therapy) and 87 at six month (45 usual care, 42 behavioural 
therapy) follow up (see Figure 1).  
Figure 1 about here 
 
Missing data for these cases was dealt with using the ‘Last value carried 
forward/backward’ [23] approach, which is widely used in the calculation of 
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health status data where particular time points are missing for some individual 
patients whilst still being available at other relevant time points. 
Intervention costs 
The total cost of the intervention per patient differed across the intervention 
group as participants received between 4 and 18 therapy sessions (range 4-18, 
mean 9.3, SD 2.6) with each session lasting a mean of 58 minutes (range 30-
89, SD 10.7) [13]. Therefore, the cost of the intervention across the 41 
Behavioral Therapy participants was £1961 per participant.  
Missing data 
The resource use questionnaire was not completed by 7 participants from the 
behavioural therapy group and 4 participants from usual care group at both the 
three month and six month follow up. Eight of these participants subsequently 
withdrew completely from the study (2 Usual Care, 6 Behavioural Therapy) along 
with a further 3 participants (3 Behavioural Therapy). Additionally, due to the 
high levels of missing data from 3 participants (2 Usual Care and 1 Behavioural 
Therapy), these participants, together with the 11 who withdrew from the study, 
were eliminated from further analysis.  
The same method was also adopted for the missing data for the SADQH21 
analysis There were 4 partially completed SADQH21 questionnaires (3 Usual 
Care, 1 Behavioural Therapy) that required the above missing data method and 
1 participant (1 Behavioural Therapy) that was discounted completely as all 
scores were missing.  
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Therefore, the final complete case analysis was based on 50 (54.9%) Usual Care 
participants and 41 (45.1%) Behavioural Therapy participants. These included, 
34 (37.4%) women and they had a mean age of 65.9 years (SD 13.53) 
 
Table 2 about here. 
 
Service use costs 
At three months, the cost per patient was less in the behavioural therapy group 
for Speech and Language Therapist, Occupational Therapist, Physiotherapist and 
Home Help contacts compared with usual care. At six months the follow up, the 
cost per patient was greater in the behavioural therapy group for General 
Practitioner, Mental Health Nurse and Practice Nurse contacts (see Table 3). 
When the per patient cost of the intervention (£1961) was added in to the total 
difference in costs over 3 months, the overall difference in costs between the 
control group (£-11.60, SD 798.3) was statistically significant compared with the 
intervention group (£1821.50, SD 923.2) (p < 0.01). However this would be 
expected because of the increase due to the Intervention cost. Results are 
shown in Table 3.  
Table 3 about here. 
24 month extrapolation of 6 month resource use data 
The relatively short follow up period of three months (between the three month 
and six month follow ups), necessitated extrapolating the % increase/decrease 
in resource utilisation for the 3 month period incrementally to 24 months. GP 
visits led to an increase of £191.80 in the intervention group compared to an 
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increase of £15.40 costs per patient in the control group. With overall total 
costs, there was a greater increase of costs seen in both arms of the trial. 
However, the intervention arm had the most cost savings with visits to or from 
the Speech and Language Therapist of £88.80 per patient compared to £79.10 
the control. Visits to the occupational therapist led to a saving of £75.80 per 
patient in the intervention group, as compared to a £51.60 increase in the 
control group.  
The largest cost saving was seen was in Home Help costs where there was a 
saving of £256.50 in the intervention group compared to an increase of £952.30 
in the control group. Cost differences between the control group and the 
intervention group resulted in an overall increase of £1541.70 in the control 
group, as compared to an overall increase of £1,388.90 in the intervention 
group. This resulted in a saving of £152.80, but none of the differences were 
statistically significant (p=0.26) (Table 4).  
Overall, differences between the control group and the intervention group 
resulted in per patient cost savings of £93.15 in the intervention group, 
compared to a cost per patient increase of £39.90 in the control, but none of the 
differences were statistically significant (p=0.36) (Table 4). 
Table 4 about here.  
Differences in the costs of the intervention resulting from the number of sessions 
received were also explored. Using an incremental extrapolation to 24 months 
based on the % increase/decrease over the three months between three and six 
month follow ups, GP visits led to a cost per patient of £77.89  in the 10 – 18 
session group compared to £373.27 in the 4 – 9 session  group. There were cost 
per patient savings of £119.00 in the Speech and Language Therapist 10 – 18 
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session group, compared to £35.65 in the 4 – 9 session group. Results are 
shown in Tables 5 and 6.  
Tables 5 and 6 about here. 
SADQH-21 results 
A decrease in SADQH-21 score indicates an improvement in mood.  The mean 
SADQH-21 for the control group at baseline was 19.7 compared to 23.6 for the 
intervention group– a difference of 3.9 (p=0.08). In the behavioural group the 6 
month score was 20.4 compared to the control group score of 17.3. This 
resulted in a mean increase of 0.7 in the control group, compared to a mean 
decrease of 6 in the behavioural group (p = 0.003) 
When comparing the SADQH-21 results by attendees in each group, the mean 
baseline value for the 4 – 9 session group was 24.3 compared to 22.9 in the 10 
– 18 session group. At 6 months, the 4 – 9 session group results showed a mean 
difference of -7 as compared to -5.5 at 6 months for the 10 – 18 months, but no 
differences were statistically significant (Table 7).       
Table 7 about here. 
The treatment group was associated with an incremental cost effectiveness ratio 
of £263 per additional point reduction in the SADQH21. Uncertainty in the 
incremental cost effectiveness ratio was estimated through bootstrapping. A cost 
effectiveness acceptability curve was plotted which showed a 100% probability 
that the adjustment group would be considered cost effective if purchasers were 
willing to pay up to £263 per point reduction in the SADQH21 score.  
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Discussion 
The primary analysis was a cost analysis of behavioural therapy compared with 
usual care for treating low mood in stroke patients with aphasia. Cost results 
from the CALM trial indicated some encouraging differences between the 
behavioural therapy group as compared to the usual care group resulting in 
savings in certain areas of resource utilisation over the six months follow up 
period. Before the mean intervention costs of £1,961 were added in, there were 
overall savings of £139.24 in the intervention group compared to £11.59 in the 
control group, with the greatest difference in home help costs. There was a 
saving of £56.20 in the intervention group compared to an increase of £61.40 in 
the control group. Additionally, as seen from the incremental 
%increase/decrease over 24 months analysis, there was some evidence to 
suggest these effects may persist over time. Overall there was an increase in 
costs seen in both groups, with the largest difference in home help costs with a 
cost per patient saving of £256.50 in the intervention group compared to an 
increase of £952.30 in the control group. Overall there were costs of £1541.70 in 
the control group compared to £1,388.90 in the intervention group – a saving of 
£152.80.  
The analysis of the SADQH-21 data showed that participants benefitted from 
behavioural therapy [13]. The behavioural therapy group showed a decrease of 
6 on the SADQH-21 indicating an improvement in mood, whereas the control 
group increased by 0.7. This difference was statistically significant (p = 0.003) 
Additionally, in the ‘group session’ analysis, there was a decrease of 7 in the 
SADQH21 score in participants who had 4 – 9 sessions compared to a 5.5 
decrease in those who received  10 - 18 sessions. This suggests that those who 
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received fewer behavioural therapy sessions benefited more in terms of mood 
improvement and this reduced the costs of the therapy.  Those who were not 
benefitting were given more sessions. 
 
The study was limited by the resource use measure, which was a self-report 
questionnaire with simplified response categories (Never, Sometimes, Often) to 
facilitate completion by participants with aphasia, although carers were able to 
assist with completion where necessary. It is possible that participants did not 
accurately recall service use over the previous three months, but this should 
have been present to the same degree across both groups.   
We did not include a formal measure of health-related quality of life so were 
unable to calculate quality adjusted life years (QALYs) or an incremental cost-
effectiveness ratio.  Such a measure should be included in future studies but 
would need to be suitable for patients with aphasia.  
Although we recorded whether or not participants received antidepressant 
medication (recorded as yes/no), we did not have further detail on type, 
duration and dose and therefore were unable to include this in the cost analysis. 
Such information should be obtained in a future study.  
A recent study by Ekers et al [24] looking at ‘behavioural activation’ by non-
specialists resulted in a promising incremental cost effectiveness ratio (ICER) of 
£5756 and a 97% probabilistic analysis that the therapy was cost effective at 
NICE’S threshold of £20,000 when using the Beck Depression Inventory–II (BDI-
II) as the Health Related Quality of Life (HRQoL) measure.  However, this was 
based on a per participant cost of £247. 
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Additionally, a 2012 study by Humphreys et al [25] aimed to evaluate the Cost-
effectiveness of an adjustment group for people with multiple sclerosis and low 
mood. The ICER indicated that the cost per point reduction on the BDI-II was 
£118. This indicated that in the short term, the adjustment group programme 
was cost effective when compared with usual care, for people with multiple 
sclerosis presenting with low mood. However, the authors reported that the 
longer-term costs needed to be assessed. 
 
There was a significant effect of the intervention on mood (SADQH21) The Cost-
effectiveness acceptability curve illustrates the ‘acceptable’ cost-effective ratio. 
i.e. the maximum threshold willingness to pay for a unit of effect . Our results 
indicate that the treatment was more likely to be cost effective compared to 
usual care for stroke patients with aphasia presenting with low mood, assuming 
a willingness to pay threshold of more than £263 per point reduction in the 
SADQH21. The cost-effectiveness of the intervention depends on how much 
purchasers are willing to pay for reductions in depression scores. Further 
economic evaluations of psychological interventions should focus on costs that 
are expected to vary between groups as a result of an intervention.  
 
Overall the behavioural therapy was found to improve mood and resulted in 
some savings in resource utilisation over the six months follow up. These results 
are promising and suggest further evaluation of behavioural therapy is 
warranted. The follow up period was six months after randomisation (and three 
months after the intervention period finished) which did not allow us to assess 
whether costs and savings were maintained. A longer follow up period with a 
larger sample size is required to evaluate the accuracy of the 24 month 
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extrapolation conducted in this analysis.  Future research should also assess the 
optimum number of therapy sessions. 
 
Clinical Messages 
 
• A behavioural treatment group for stroke patients with aphasia has the 
potential to reduce the overall costs of clinical services in the long term 
• There was a significant improvement in mood in the intervention group 
after 6 months  
• Every point reduction on the SADQH21 scale cost £263 
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Figure 1: Consort diagram of patients randomised and lost to follow-up 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients randomly allocated 
n = 105 
Outcome assessments at 3 
months 
Treatment as Usual (TAU) 
n = 48 
Outcome assessments at 3 
months 
Behavioural Therapy (BT) 
n = 40 
Outcome assessments at 6 
months 
Treatment as Usual (TAU) 
n = 45 
Outcome assessments at 6 
months 
Behavioural Therapy (BT) 
n = 42 
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Table1: Unit Costs 2011 
Resource 
Unit cost 
(£) 
Source 
General practitioner  36 PSSRU 2011 
Speech and Language 
Therapist 34 PSSRU 2011 
Occupational Therapist  34 PSSRU 2011 
Physiotherapist  34 PSSRU 2011 
Mental Health Nurse 76 PSSRU 2011 
Practice nurse  51 PSSRU 2011 
Home-care services  32 PSSRU 2011 
      
Band 8b Clinical 
Psychologist 76 PSSRU 2011 
Band 5 Assistant 
Psychologist 135 PSSRU 2011 
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Table 2: Category counts for resource use at 3 months and 6 months follow up  
    3 months 6 Months 
Resource Category Frequency 
Usual 
care 
Behaviour 
therapy 
Frequency 
Usual 
care 
Behaviour 
therapy 
General 
Practitioner 
Never 0 10 13 0 10 10 
Sometimes 3 30 22 3 28 20 
Often 4 10 6 4 12 11 
Speech and 
Language 
Therapist 
Never 0 26 19 0 32 23 
Sometimes 5 11 7 5 9 5 
Often 10 13 15 10 9 13 
Occupational 
Therapist 
Never 0 40 29 0 39 31 
Sometimes 8 6 7 8 7 8 
Often 17 4 5 17 4 2 
Physiotherapi
st 
Never 0 34 25 0 38 28 
Sometimes 13 6 8 13 5 7 
Often 26 10 8 26 7 6 
Mental Health 
Nurse 
Never 0 45 38 0 47 36 
Sometimes 3 4 2 3 3 3 
Often 6 1 1 6 2 2 
Practice 
Nurse 
Never 0 30 20 0 23 19 
Sometimes 3 15 15 3 19 17 
Often 4 5 6 4 8 5 
Home Help 
Never 0 39 26 0 37 27 
Sometimes 24 2 2 24 2 3 
Often 48 9 13 48 11 11 
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Table 3: Differences over 3 months (including Intervention costs) 
  TAU     CBT         
Mean per patient costs for Baseline 
N Mean Std. Dev N Mean Std. Dev Difference 
p-
value 
GP Cost Baseline 50 £90.72 £49.88 41 £76.21 £55.35 14.5 (-7.4 to 36.4) 0.192 
SLT Cost Baseline 50 £121.92 £142.76 41 £149.85 £154.12 -27.9 (-89.8 to 34.0) 0.373 
OT Cost Baseline 50 £79.70 £174.09 41 £118.09 £202.66 -38.4 (-116.9 to 40.1) 0.334 
PT Cost Baseline 50 £231.06 £360.61 41 £260.72 £357.09 -29.7 (-179.9 to 120.6) 0.696 
MHN Cost Baseline 50 £23.56 £71.40 41 £21.87 £82.54 1.7 (-30.4 to 33.8) 0.917 
Nurse Cost Baseline 50 £62.22 £81.06 41 £81.35 £85.81 -19.1 (-53.9 to 15.7) 0.278 
Home Help Cost Baseline 50 £307.20 £600.93 41 £524.49 £717.15 -217.3 (-491.8 to 57.2) 0.119 
Total Cost Baseline 50 £916.38 £898.86 41 £1,232.59 £1,009.89 -316.2 (-714.1 to 81.7) 0.118 
  TAU     CBT         
Mean per patient 3 months 
N Mean Std. Dev N Mean Std. Dev Difference 
p-
value 
GP Cost 3 Months 50 £92.74 £51.28 41 £89.74 £55.80 2.9 (-19.3 to 25.3) 0.790 
SLT Cost 3 Months 50 £88.74 £131.41 41 £125.80 £153.81 -37.1 (-96.5 to 22.4) 0.218 
OT Cost 3 Months 50 £85.27 £175.95 41 £82.60 £158.93 2.7 (-67.9 to 73.2) 0.940 
PT Cost 3 Months 50 £168.98 £321.50 41 £206.57 £330.55 -37.6 (-173.9 to 98.7) 0.585 
MHN Cost 3 Months 50 £14.14 £56.52 41 £38.00 £108.35 -23.9 (-58.9 to 11.2) 0.180 
Nurse Cost 3 Months 50 £86.29 £86.26 41 £82.35 £82.56 3.9 (-31.5 to 39.4) 0.825 
Home Help Cost 3 Months 50 £368.64 £644.24 41 £468.29 £684.30 -99.7 (-377.0 to 177.7) 0.477 
Total Cost 3 Months 50 £904.80 £901.04 41 £1,093.34 £865.04 -188.5 (-559.1 to 181.9) 0.315 
  TAU     CBT         
Overall N Mean Std. Dev N Mean Std. Dev Difference 
p-
value 
Overall Costs (Baseline + 3 Months) 50 £1,821.18 £1,613.17 41 £2,325.93 £1,700.48 -504.7 (-1196.7 to 187.1) 0.151 
Difference in costs over 3 months 50 -£11.59 £798.31 41 -£139.24 £802.93 127.6 (-207.4 to 462.7) 0.451 
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Difference in costs over 3 months + 
Intervention Costs 50 -£11.59 £798.31 41 £1,821.51 £923.21 
-1833.1 (-2191.7 to -
1474.5) 
0.000 
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Table 4: Incremental and % differences in costs per patient over 24 months (not 
including intervention costs) 
  
% Increases or 
savings after 3 months 
Incremental increases 
or savings over 24 
months 
  Usual Care 
Behavioural 
Therapy 
Usual Care 
Behavioural 
Therapy 
General 
Practitioners 
£94.80 £105.70 £15.40 £191.80 
Speech and 
Language 
Therapist 
£64.60 £105.60 -£79.10 -£88.80 
Occupational 
Therapist 
£91.20 £57.80 £51.60 -£75.80 
Physiotherapist £123.60 £163.70 -£150.10 -£166.10 
Mental Health 
Nurse 
£8.50 £66.00 -£13.70 £1,777.00 
Practice Nurse £119.70 £83.40 £765.30 £7.30 
Home Help £442.40 £418.10 £952.30 -£256.50 
Total Cost £944.70 £1,000.20 £1,541.70 £1,388.90 
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Table 5: Differences over 3 months by number of treatment sessions received costs 
Behavioural therapy 4 - 9 Sessions 10  - 18 Sessions     
  n Mean 
Std. 
Dev 
n Mean 
Std. 
Dev 
Difference 
p-
value 
General Practitioner 
Cost 3 months 21 £74.4 £56.6 20 £78.1 £55.4 
-3.72  
(-39.1 to 31.7) 
0.833 
Speech and Language 
Therapist Cost 3 
months 21 £117.4 £141.3 20 £183.9 £163.1 
-66.6 (-162.8 to 
29.7) 
0.170 
Occupational Therapist 
Cost 3 months 21 £39.8 £100.0 20 £200.3 £249.1 
-160.4 (-279.3 to 
-41.6) 
0.009 
Physiotherapist Cost 3 
months 21 £192.8 £267.6 20 £332.0 £427.4 
-139.2 (-363.2 to 
84.9) 
0.216 
Mental Health Nurse 
Cost 3 months 21 £11.2 £51.4 20 £33.1 £106.3 
-21.8 (-74.2 to 
30.5) 
0.404 
Practice Nurse Cost 3 
months 21 £67.5 £75.1 20 £95.9 £95.5 
-28.4 (-82.5 to 
25.8) 
0.296 
Home Help Cost 3 
months 21 £365.7 £624.8 20 £691.2 £784.0 
-325.5 (-772.2 to 
121.2) 
0.149 
Total Cost 3 months 
21 £868.9 £801.6 20 £1,614.5 £1,082.1 
-745.6 (-1345.1 to 
-146.0) 
0.016 
  4 - 9 Sessions 10  - 18 Sessions     
  
n Mean 
Std. 
Dev 
n Mean 
Std. 
Dev 
Difference 
p-
value 
General Practitioner 
Cost 6 months 21 £93.6 £58.1 20 £85.7 £54.5 
7.92 (-27.7 to 
43.5) 
0.655 
Speech and Language 
Therapist Cost 6 
months 21 £111.1 £153.2 20 £141.3 £156.8 
-30.2 (-128.2 to 
67.8) 
0.536 
Occupational Therapist 
Cost 6 months 21 £108.2 £191.5 20 £55.8 £114.4 
52.4 (-47.9 to 
152.7) 
0.297 
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Physiotherapist Cost 6 
months 21 £212.4 £332.8 20 £200.4 £336.7 
11.9 (-199.5 to 
223.5) 
0.909 
Mental Health Nurse 
Cost 6 months 21 £22.4 £70.9 20 £54.3 £137.4 
-31.9 (-100.5 to 
36.7) 
0.352 
Practice Nurse Cost 6 
months 21 £84.5 £79.5 20 £80.1 £87.6 
4.4 (-48.5 to 
57.3) 
0.866 
Home Help Cost 6 
months 21 £292.6 £568.3 20 £652.8 £758.9 
-360.2 (-782.4 to 
61.9) 
0.092 
General Practitioner 
Cost 6 months 21 £924.8 £732.5 20 £1,270.4 £972.7 
-345.6 (-887.8 to 
196.6) 
0.205 
  4 - 9 Sessions 10  - 18 Sessions     
  
N Mean 
Std. 
Dev 
N Mean 
Std. 
Dev 
Difference 
p-
value 
Overall Cost 
21 £1,793.6 £1,319.1 20 £2,884.8 £1,901.1 
-1091.2 (-2120.5 
to -61.8) 
0.038 
Diff in costs 
21 £55.9 £786.3 20 -£344.1 £787.5 
399.9 (-97.3 to 
897.3) 
0.112 
Actual cost of session 
21 £1,597.6 £330.7 20 £2,342.1 £386.6 
-744.5 (-971.5 to 
-517.6) 
<0.001 
Total cost including 
session cost 21 £3,391.2 £1,313.0 20 £5,226.9 £2,020.1 
-1835.7 (-2906.7 
to -764.7) 
0.001 
Change in costs over 
3months 21 £3,447.1 £1,520.8 20 £4,882.8 £2,062.4 
-1435.7 (-
2576.5to -294.9) 
0.015 
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Table 6: Incremental and % differences in costs per patient over 24 months by 
low or high use of session costs (not including intervention costs and not 
including OT Outlier costs) 
  Number. Of Sessions 
  4 - 9 10 - 18 
  
Incremental 
Changes over 24 
months 
General 
Practitioners 
£373.3 £77.9 
Speech and 
Language 
Therapist 
-£35.4 -£119.0 
Occupational 
Therapist 
*- *- 
Physiotherapist £205.7 -£194.6 
Mental Health 
Nurse 
£2,849.6 £1,706.9 
Practice Nurse £322.6 -£57.4 
Home Help -£231.2 -£215.3 
TotalCost £3,484.4 £1,198.6 
*Left empty 
because of outlier 
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Table 7: SADQH21 Analysis between baseline and 6 months 
  Group n Mean 
Std. 
Dev 
Group n Mean 
Std. 
Dev 
95% 
Confidence 
Interval of the 
Difference 
p - 
value 
SADQH21 
Baseline 
Usual 
care 
49 19.7 8.72 
Behaviour 
therapy 
39 23.6 12.33 
-3.95 (-8.42 to 
0.511) 
0.082 
SADQH21 3 
Months 
Usual 
care 
49 16.6 9.94 
Behaviour 
therapy 
39 14.1 8.08 
2.51 (-1.39 to 
6.42) 
0.204 
SADQH21 6 
Months 
Usual 
care 
49 20.4 9.80 
Behaviour 
therapy 
39 17.3 9.78 
3.07 (-1.10 to 
7.25) 
0.147 
SADQH21 
Difference 
(between 
baseline and 6 
months) 
Usual 
care 
49 0.7 8.78 
Behaviour 
therapy 
39 -6 12.80 
7.03 (2.45 to 
11.61) 
0.003 
                      
  Group n Mean 
Std. 
Dev 
Group n Mean 
Std. 
Dev 
95% 
Confidence 
Interval of the 
Difference 
p - 
value 
SADQH21 
Baseline 
4 - 9 21 24.3 12.95 10 - 18 18 22.9 11.88 
1.43 (-6.68 to 
9.55) 
0.723 
SADQH21 3 
Months 
4 - 9 21 13.7 7.93 10 - 18 18 14.6 8.45 
-0.89 (-6.21to 
4.43) 
0.737 
SADQH21 6 
Months 
4 - 9 21 17.3 11.14 10 - 18 18 17.3 8.23 
0 (-6.45 to 
6.45) 
1.000 
SADQH21 
Difference 
4 - 9 21 -7.0 15.38 10 - 18 18 -5.5 9.33 
-1.43 (-9.86 to 
6.99) 
0.732 
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(between 
baseline and 6 
months) 
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Objective 
To evaluate the cost effectiveness of a behavioural therapy intervention shown to be clinically 
effective in comparison with usual care for stroke patients with aphasia. 
Design  
Randomised controlled trial with comparison of costs and calculation of incremental cost 
effectiveness ratio. 
Setting  
Community 
Participants 
Participants identified as having low mood on either the Visual Analog Mood Scale sad item (>50) or 
Stroke Aphasic Depression Questionnaire Hospital version 21 (SADQH21) (>6) were recruited.  
Interventions 
Participants were randomly allocated to behavioural therapy or usual care using internet-based 
randomisation generated in advance of the study by a clinical trials unit. 
Main measures 
Outcomes were assessed at six months after randomisation, blind to group allocation. The costs 
were assessed from a service use questionnaire. Effectiveness was defined as the change in 
SADQH21 scores and a cost-effectiveness analysis was performed comparing the behavioural group 
with the usual care control group. The cost analysis was undertaken from the perspective of the UK 
NHS and Social Services.  
Results 
At 6 months the SADQH21 score for the intervention group was 20.4 compared to the control group 
value of 17.3. This resulted in a mean increase of 0.7 in the control group, compared to a mean 
significant different decrease of 6 in the intervention group (p = 0.003). The Incremental Cost-
Effectiveness Ratio indicated that the cost per point reduction on the SADQH21 was £263. 
Conclusion 
The behavioural therapy was found to improve mood and resulted in some encouraging savings in 
resource utilisation over the six months follow up. 
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